These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18700253)

  • 21. The changing attitude of European VCs.
    Mitchell P
    Nat Biotechnol; 2004 Apr; 22(4):479. PubMed ID: 15085807
    [No Abstract]   [Full Text] [Related]  

  • 22. Calculating the value & risk in licensing deals. 20-21 November 2002, Brussels, Belgium.
    Contrafouris Y
    IDrugs; 2003 Jan; 6(1):21-2. PubMed ID: 12838965
    [No Abstract]   [Full Text] [Related]  

  • 23. Japanese firms broaden investment focus to early biotech.
    Louët S; Sipp D
    Nat Biotechnol; 2004 Aug; 22(8):931-2. PubMed ID: 15286631
    [No Abstract]   [Full Text] [Related]  

  • 24. China's biotech experiments.
    Hepeng J
    Nat Biotechnol; 2005 Dec; 23(12):1472-3. PubMed ID: 16421994
    [No Abstract]   [Full Text] [Related]  

  • 25. Andrew Gearing. Interview by Suzanne Berry.
    Berry S
    Trends Biotechnol; 2002 Sep; 20(9):404-5. PubMed ID: 12175773
    [No Abstract]   [Full Text] [Related]  

  • 26. Divining the path to a successful European exit.
    Buch HK; Gustafsson AC; Drvota V; Sundberg CJ
    Nat Biotechnol; 2011 Mar; 29(3):205-7. PubMed ID: 21510008
    [No Abstract]   [Full Text] [Related]  

  • 27. Michigan's next wave of biopharmaceutical entrepreneurship.
    Kerppola R; van de Walle M; Surine S
    Nat Biotechnol; 2003 Sep; 21(9):1109-11. PubMed ID: 12949575
    [No Abstract]   [Full Text] [Related]  

  • 28. Tech transfer fails to translate into startups.
    Lawrence S
    Nat Biotechnol; 2007 Jun; 25(6):616. PubMed ID: 17557089
    [No Abstract]   [Full Text] [Related]  

  • 29. Entrepreneurship.
    Yetisen AK; Volpatti LR; Coskun AF; Cho S; Kamrani E; Butt H; Khademhosseini A; Yun SH
    Lab Chip; 2015; 15(18):3638-60. PubMed ID: 26245815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bad behavior.
    Potts RO
    Nat Biotechnol; 2000 Oct; 18(10):1021. PubMed ID: 11016998
    [No Abstract]   [Full Text] [Related]  

  • 31. How Indian biotech is driving innovation.
    Nogrady B
    Nature; 2018 Dec; 564(7735):S53-S55. PubMed ID: 30542184
    [No Abstract]   [Full Text] [Related]  

  • 32. Innovative startups 2013.
    Huggett B
    Nat Biotechnol; 2014 Feb; 32(2):127. PubMed ID: 24509750
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapeutic cancer vaccine survives biotech bust.
    Ledford H
    Nature; 2015 Mar; 519(7541):17-8. PubMed ID: 25739610
    [No Abstract]   [Full Text] [Related]  

  • 34. Changing partners.
    Nat Biotechnol; 2002 Sep; 20(9):855. PubMed ID: 12205487
    [No Abstract]   [Full Text] [Related]  

  • 35. Bioscience industry in metro Atlanta.
    Allen CR
    Drug Discov Today; 2005 Feb; 10(4):237-9. PubMed ID: 15708740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. San Diego.
    Howard K
    Nature; 2003 Dec; 426(6967):689. PubMed ID: 14668871
    [No Abstract]   [Full Text] [Related]  

  • 37. The impact of two pharmaceutical risk-sharing agreements on pricing, promotion, and net health benefits.
    Zaric GS; Xie B
    Value Health; 2009; 12(5):838-45. PubMed ID: 19490563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Europe discovers bioentrepreneurship.
    Haycock P
    Nat Biotechnol; 1998 May; 16 Suppl():6. PubMed ID: 9591249
    [No Abstract]   [Full Text] [Related]  

  • 39. Biotech booms in China.
    Ellis S
    Nature; 2018 Jan; 553(7688):S19-S22. PubMed ID: 29345681
    [No Abstract]   [Full Text] [Related]  

  • 40. Notable licensing deals in the biopharma industry in the third quarter of 2017.
    D'Souza P
    Drugs Today (Barc); 2017 Oct; 53(10):553-557. PubMed ID: 29286057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.